The largest database of trusted experimental protocols

Superfect

Manufactured by Qiagen
Sourced in United States, Germany, Spain, United Kingdom

Superfect is a transfection reagent developed by Qiagen. It is designed to facilitate the efficient delivery of DNA, RNA, or other molecules into a variety of cell types for the purpose of gene expression, gene silencing, or other experimental applications. The reagent is formulated to promote the uptake and intracellular transport of the target molecules, enabling researchers to study their effects on cellular processes.

Automatically generated - may contain errors

166 protocols using superfect

1

Plasmid Transfection and siRNA Knockdown of p27 in Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endothelial cells were transfected on 6-cm culture dishes with 3 μg plasmid DNA and 25 μl Superfect (Qiagen) as described previously, with a transfection efficiency of 40% [44 (link)]. Endogenous p27 was down-regulated by transfection with 2 different siRNAs (p27 siRNA-1 duplex sense strand: 5′-GCGCAAGUGGAAUUUCGAU-3′; p27 siRNA-2 duplex sense strand: 5′-GAGCCAACAGAACAGAAGA-3′) using JetSi reagent (Eurogentec) according to the manufacturer’s instructions. Expression of nuclear- or mitochondrially targeted p27 after knockdown of the endogenous protein was achieved by transfection with Superfect (Qiagen) 18 hours later, using Superfect as described above.
+ Open protocol
+ Expand
2

Stable and Transient Transfection of HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells of the HEK293T cell line adapted to grow in 0.5% FBS v/v UltraCULTURE™, termed 293TUC.5, were stably transfected with 10 μg of either pETIP-NucB, pETIP-IgκNucB, pETIP-ThorNucB and pGTIP as control using SuperFect (QIAgen) at a 1:5 DNA:SuperFect mass ratio on a 100 mm dish according to manufacturer's instructions and selected in 100 ng/mL puromycin from 48 h post transfection, along with a plasmid-null negative control. Puromycin-resistant populations arising from this procedure were named as indicated in Fig. 4. Transient transfection with the above cells and plasmids was performed as above except tetracycline was added to 1 μg/mL 24 h post transfection, cell media was characterised 48 h post transfection and puromycin selection was not performed.
+ Open protocol
+ Expand
3

Transient HCV Particle Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The transcribed viral genome was delivered into Huh7 cells by transfection (SuperFect; Qiagen, Germany) according to the manufacturer's instructions. Supernatants harboring the released HCV particles were collected 72 h post-transfection, filtered through 0.45 μm pore size filters and stored at −80°C for further use.
+ Open protocol
+ Expand
4

Measuring Mitochondrial Function in Cultured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of human serum on the mitochondrial function of cultured cells was evaluated by measuring intracellular ATP content as described previously with minor modifications.5 (link) In short, we selected G418 resistant stable colonies from Hepa1c1c7 cells that had been transfected with pRL-TK using SuperFect (Qiagen, Germantown, MD, USA) for 3 weeks and stored. Cells showed stable Renilla luciferase activity. pRL-mTK-transfected mouse Hepa1c1c7 cells (5×104/well) in a 96-well plate were treated with 10 µL of heat-inactivated-serum samples for 48 h. The ATP content of the treated cells was determined using the luciferin-luciferase reaction with the CellTiter-Glo luciferase kit (Promega), with the output being normalized to Renilla luciferase activity. The intracellular ATP content of CSS-treated control cells was 65.1±2.7 nM. The ATP concentration of 10% sample serum-treated cells could be calculated from a standard curve of ATP concentrations (nM)=(% control+18.24)/1.817. ATP content was expressed as a percentage of CSS-treated control. The intra- and interassay coefficients of variation for these methods were <6.0%.
+ Open protocol
+ Expand
5

Quantifying Cyp1b1 Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dual-luciferase assay (Promega, Madison, WI) was performed in BEAS-2B cells double transfected with 2 plasmid constructs using Qiagen SuperFect. The firefly luciferase construct p1.1 contained the rat Cyp1b1 5’-UTR and 1.0 Kb of the proximal 5’-flanking sequence. The renilla luciferase construct was pRL-TK (Promega). Cyp1b1 promoter activities were determined by the dual-luciferase assay, which entailed normalizing the firefly luciferase activities against those of renilla luciferase.
+ Open protocol
+ Expand
6

Evaluating EV71 IRES Activity in SF268 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bicistronic reporter plasmid pRHF-EV71-5′UTR, which contains the EV71 IRES between Renilla and Firefly luciferase open reading frames13 (link) was used as the template for synthesis of capped reporter RNA using the MAXIscript kit (ThermoFisher). SF268 cells were seeded in 24-well plates. Two hundred ng of reporter RNA, 5 µl of SuperFect (Qiagen), and 400 µl of RPMI with 10% fetal calf serum were combined and added to one well of cells. Cells were incubated at 37 °C for 4 h, medium was changed, and various concentrations of DMA-135 were added. Two days after transfection, IRES activity was determined by measuring Renilla luciferase (RLuc) and Firefly luciferase (FLuc) activities using a dual-luciferase reporter assay system (Promega).
+ Open protocol
+ Expand
7

Dual-Luciferase Assay of MYC Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells growing in 6-well plates were transfected with 1.5 μg of TOPFlash (Addgene), pGL3 basic vector (Promega) or pGL3-MYC-Luc promoter vector (29 (link)) and SV-40-Renilla-Luc in the presence of Superfect (Qiagen). The pGL3-pMYC-Luc vector was also mutated using the QuickChange II kit (Agilent Technologies). At 48 h after transfection, the cells were lysed in passive lysis buffer. Lysates were analyzed with the Dual-Luciferase assay kit (Promega).
+ Open protocol
+ Expand
8

MHV68 and KSHV Viral Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MHV68 bacterial artificial chromosome (BAC) has been described elsewhere (Adler et al., 2000 (link)), and the construction of the R443I muSOX mutant (ΔHS) was previously described (Richner et al., 2011 (link)). MHV68 was produced by transfecting NIH 3T3 cells with BAC DNA using SuperFect (Qiagen). Virus was amplified in NIH 3T12 cells and titered by plaque assay. Cells were infected with MHV68 at an MOI of 5 for 24 h unless otherwise noted.
KSHV BAC mutagenesis has been described elsewhere (Brulois et al., 2012 (link)). The mutant BAC clone was sequenced to confirm the P176S mutation, once after cell line construction, and once after 2 weeks of cell maintenance. KSHV was reactivated by adding 1 μg/ml of doxycycline and 1 μg/ml of sodium butyrate for 48 h. Reactivation efficiency was determined by qPCR on isolated DNA and found to be equivalent between WT and P176S.
+ Open protocol
+ Expand
9

Fractionation and Isolation of Adipose Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
To fractionate SV cells, adipocytes and SVP, we pooled subcutaneous (inguinal, interscapular) or visceral (gonadal and retroperitoneal) WATs. After 2 h of slow shaking at 37 °C, the suspension was spun at 800 g for 10 min; the resultant floating layer was the adipocyte layer and the pellet was a crude SV fraction. The floated adipocyte layer was collected for RNA extraction. The SV pellet was then resuspended in erythrocyte lysis buffer (0.83% NH4Cl in H2O) for 8 min, passed through a 70 μm mesh and then spun at 1,200 g for 5 min. The pellet was washed once in 1 × PBS, resuspended and passed through 40 μm mesh and spun at 1,200 g for 5 min. The pellet was resuspended in growth media (DMEM supplemented with 10% foetal bovine serum (FBS)). The SVP tubes that remained on the 70 μm mesh were washed off and collected in growth media and cultured on microscope coverslips that were precoated with 1% fibronectin (Sigma: item no.: F1141). SVPs were imaged 12 h later for GFP occupancy10 (link). For transfection experiments, expression vector harbouring cDNA for PDGFRβ was purchased from GE Dharmacon Openbiosystems (item no.: 30060666). Cells were reverse-transfected using Superfect (Qiagen: item no.: 301305) transfection regent following the manufacturer’s protocol. Cell media (DMEM supplemented with 10% FBS) was replaced 12 h post-transfection.
+ Open protocol
+ Expand
10

Stable PAG Knockdown in Jurkat T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PAG protein expression was stably knocked-down in Jurkat T cells by RNA interference using Mission shRNA plasmids (TRCN0000123273, Sigma). Lentiviral particles were generated by transfecting HEK293T cells with pMD2G, psPAX2, and the shRNA plasmid using SuperFect (Qiagen). T cells were transduced by centrifugation and selected with puromycin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!